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A B S T R A C T   
Background: Selenium (Se) is a trace element with a narrow safety margin. 
Objectives: To evaluate the cross-sectional and longitudinal dose-response association between Se exposure and 
measures of impaired physical function and disability in older adults. 
Design: NHANES 2011–2014 cross-sectional (US, n = 1733, age ≥60 years) and Seniors-ENRICA-2 2017–2019 
cross-sectional and longitudinal (Spain, n = 2548 and 1741, respectively, age ≥65 years) data were analyzed. 
Whole blood and serum Se levels were measured using inductively coupled plasma-mass spectrometry. Lower- 
extremity performance was assessed with the Short Physical Performance Battery, and muscle weakness with 
a dynamometer. Incident mobility and agility limitations, and disability in instrumental activities of daily living 
(IADL) were ascertained with standardized questionnaires. Analyses were adjusted for relevant confounders, 
including physical activity. Results across studies were pooled using random-effects meta-analysis. 
Results: Meta-analyzed odds ratios (95% confidence interval) per log2 increase in whole blood Se were 0.54 
(0.32; 0.76) for weakness, 0.59 (0.34; 0.83) for impaired lower-extremity performance, 0.48 (0.31; 0.68) for 
mobility limitations, 0.71 (0.45; 0.97) for agility limitations, and 0.34 (0.12; 0.56) for disability in at least one 
IADL. Analyses for serum Se in NHANES showed similar results. Findings suggest the inverse association with 
grip strength is progressive below 140 μg/L (p-value for non-linear trend in the Seniors-ENRICA-2 study = 0.13), 
and above 140 μg/L (p-value for non-linear trend in NHANES = 0.11). In the Seniors-ENRICA-2 cohort, with a 
2.2 year follow-up period, a doubling in baseline Se levels were associated with a lower incidence of weakness 
[odds ratio (95% confidence interval): 0.45 (0.22; 0.91)], impaired lower-extremity performance [0.63 (0.32; 
1.23)], mobility [0.43 (0.21; 0.91)] and agility [0.38 (0.18; 0.78)] limitations. 
Discussion: In US and Spanish older adults, Se concentrations were inversely associated with physical function 
limitations. Further studies are needed to elucidate underlying mechanisms.   
1. Introduction 
Selenium (Se) is a trace element with beneficial effects on human 
health, mainly resulting from the antioxidant capacity of selenoenzymes 
[1]. However, the safe range of exposure to Se is generally narrow, and 
both Se deficiency and excess can be harmful to human health. 
Clinical and epidemiological studies suggest that Se is a key nutrient 
* Corresponding author. Departamento Medicina Preventiva y Salud PúblicaUniversidad Autónoma de Madrid, Spain Calle del Arzobispo Morcillo 4, 28029, 
Madrid, Spain. 
E-mail addresses: esthergge@gmail.com, esthergge@gmail.com (E. García-Esquinas).  
Contents lists available at ScienceDirect 
Redox Biology 
journal homepage: www.elsevier.com/locate/redox 
https://doi.org/10.1016/j.redox.2020.101819 
Received 14 October 2020; Received in revised form 24 November 2020; Accepted 25 November 2020   
Redox Biology 38 (2021) 101819
2
for muscle health. Se deficiency due to prolonged parenteral nutrition 
has been associated with muscle pain and weakness, which are reversed 
with Se administration [2]. Cross-sectionally, Se deficiency has been 
associated with deleterious effects on muscle mass [3] and strength [4, 
5]. For instance, in 676 older women from the Women’s Health and 
Aging Study I (mean serum 117.7 μg/L), researchers found that low Se 
levels were associated with poor grip strength [4]. Similarly, among 327 
individuals aged ≥65 years living in Taipei (mean serum Se 80.6 μg/L), 
the odds of low muscle mass decreased across increasing quartiles of 
serum Se [3]. In 891 participants aged ≥65 from the InCHIANTI study 
(mean plasma Se 75.0 μg/L), those in the lowest compared to the highest 
quartile of plasma Se had higher odds of poor hip, knee, and grip 
strength [5]. Among 628 participants in the Hertfordshire cohort study, 
higher Se intake was associated with shorter 3-m walk time in women 
[6]. However, previous studies had few participants at high Se levels and 
the shape of the dose-response association between Se exposure and 
measures of physical performance at serum Se levels above 100–120 
μg/L is unclear. Moreover, there are no prospective studies evaluating 
the association between Se biomarkers and physical disability in older 
adults. Therefore, we aimed to: 1) Evaluate the cross-sectional associa-
tion and the shape of the dose-response relationship between different 
biomarkers of Se exposure (namely, whole blood and serum Se), and 
physical performance and disability in two populations of older adults 
from the United States and Europe with a wide range of Se exposure 
levels; and 2) Evaluate the prospective association between whole blood 
Se and risk of impaired physical performance and disability in an older 
adult European population. 
2. Methods 
2.1. Study population and design NHANES 
NHANES is an ongoing cross-sectional survey of a nationally repre-
sentative U.S. population conducted by the CDC’s National Center for 
Health Statistics [7]. NHANES includes an interview at home with a 
subsequent physical examination and additional interviews at mobile 
examination centers. In total, 3401 adults aged >60 years in NHANES 
2011–2014 provided information in at least one physical function var-
iable and 2280 (68.3%) had available determinations of Se in serum or 
whole blood. After exclusion of individuals with missing values on po-
tential confounders (mainly Body Mass Index [BMI] or protein intake), 
data on 1733 (whole blood) and 736 (serum) participants was available 
for analyses. NHANES was approved by the National Center for Health 
Statistics Research Ethics Review Board, and written informed consent 
was obtained from all participants (Protocol #2011–17 and Continua-
tion of Protocol #2011–17). 
2.2. Seniors-ENRICA-2 
Seniors-ENRICA-2 cohort was set up in 2017. In total, 3273 in-
dividuals were selected by sex- and district-stratified random sampling 
of all community-dwelling individuals aged ≥65 years holding a na-
tional healthcare card and living in the Madrid Autonomous Region. The 
study included a computer-assisted telephone interview (CATI) followed 
by two trained staff home visits. Information regarding lifestyles, self- 
rated health and morbidity was collected using CATI. During home 
visits, a dietary history and samples of blood were obtained, and a 
physical exam was performed. In 2019 participants were re-interviewed, 
and a new physical exam was performed. 
From the initial sample of 3273 participants, 99.7% (3263) provided 
information of at least one physical function variable and 79.4% (2598) 
had available whole blood Se determinations. From these, a total of 
2548 participants had data on all potentially important confounders and 
were included in cross-sectional analyses. In Seniors-ENRICA-2, pro-
spective analyses were performed among 1140, 1121, and 780 older 
adults with no impaired lower extremity functional performance, 
mobility or agility limitations at baseline, respectively; as well as among 
participants with follow-up information on grip strength (n = 1221) or 
frailty (n = 1734). 
Participants gave informed written consent, and the Clinical 
Research Ethics Committee of the La Paz University Hospital in Madrid 
approved the study (Protocol #HULP-PI 1793). 
3. Study variables 
3.1. Blood selenium 
In NHANES, serum and whole blood Se were measured using 
inductively coupled plasma-mass spectrometry (ELAN® DRC II) at the 
Division of Laboratory Sciences, National Center for Environmental 
Health, and Centers for Disease Control and Prevention (Atlanta, GA) 
[8]. In the Seniors-ENRICA-2, whole blood Se was measured using 
inductively coupled plasma-mass spectrometry (8900 ICP-QQQ) at the 
Department of Legal Medicine, Toxicology, and Physical Anthropology, 
School of Medicine, University of Granada (Spain). The limits of 
detection (LOD) were 4.5 μg/L for serum Se; 30.0 μg/L and 24.5 μg/L for 
whole blood Se in NHANES 2011–2012 and 2013–2014, respectively; 
and 0.3 μg/L for whole blood Se in the Seniors-ENRICA-2. No samples 
had levels below the LOD. 
Intake of Selenium, vitamins, proteins and alcohol: 
In NHANES, dietary intake of micro and macronutrients was 
measured via two 24-h dietary recall interviews. During the interview, 
participants provided details of food and beverages consumed during 
the 24-h period before the interview (midnight to midnight). Estimates 
of Se and vitamins intake from each food or beverage were calculated 
using the US Department of Agriculture’s Food and Nutrient Database 
for Dietary Studies (FNDDS) [9]. Additionally, participants provided 
information on dietary supplements, and Se intake from each product 
was summed to estimate the total daily dose for each individual. Par-
ticipants who self-reported consuming ≥1 alcoholic beverage per week 
during the preceding year were considered current drinkers, while oc-
casional drinkers (i.e. those with a consumption below 1 alcoholic 
beverage per week) were classified as non-drinkers. 
In the Seniors-ENRICA-2, habitual food consumption was assessed 
with a validated computerized diet history that collected information on 
880 foods and 34 alcoholic beverages, and used photographs to allow 
classification in 7 portion sizes [10]. The intake of vitamins and proteins 
was estimated using standard food composition tables, including the US 
FNDDS [9,11,12]. Standard beverage composition tables were used to 
estimate alcohol content. Study participants were classified as 
non-drinkers (including also occasional drinkers with average alcohol 
intakes below 1 standard unit per week), ex-drinkers, or current 
drinkers. 
List of abbreviations: 
BMI Body Mass Index 
CVD Cardiovascular Disease 
CATI Computer-assisted telephone interview 
DA Deficit Accumulation 
FNDDS US Department of Agriculture’s Food and Nutrient 
Database for Dietary Studies 
IADL Disability in Instrumental Activities of Daily living 
LOD Limit of Detection 
MEDAS Mediterranean diet adherence screener 
PHQ-9 Patient Health Questionnaire 
RDA Recommended dietary allowance 
Se Selenium 
SPPB Short Physical Performance Battery  
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In both studies, the recommended dietary allowance (RDA) was used 
as reference to categorize participants’ intakes of vitamins and Se [13].A 
minimum intake of 1.2 gr of proteins per kg of weight/day was 
considered as adequate for our study population [14]. 
3.2. Physical performance and disability 
Grip strength: Grip strength was measured with a Takei (NHANES) or 
a Jamar (Seniors- ENRICA-2) dynamometer. In the NHANES alternating 
hands were tested three times, while in the Seniors-ENRICA-2, grip 
strength was measured twice in the dominant hand. Combined grip 
strength was calculated as the sum of the largest reading from each hand 
in NHANES, and weakness was defined as the study-specific lowest 
quintile of grip strength according to sex and BMI quartiles in each 
study. 
Lower extremity physical performance: In the NHANES, lower ex-
tremity function was evaluated with the question “Without using any 
special equipment, how much difficulty do you have standing up from 
an armless straight chair?” Individuals answering “some difficulty”, 
“much difficulty” or “unable to do” were considered as having impaired 
function. In the Seniors-ENRICA-2, lower extremity function was 
assessed at baseline and follow-up with the Short Physical Performance 
Battery (SPPB), which includes three components: balance testing, 
walking speed and a sit-to-stand test [15]. Balance testing included a 
side-by-side, a semitandem and a tandem stand: 1) Participants were first 
asked to stand with their feet together. Those who were able to stand for 
10 s in this position were then tested in the semitandem stand position, 
where the heel of one foot is placed to the side of the big toe of the other 
foot. Finally, those who were able to stand for 10 s in the semitandem 
were tested in the full-tandem stand, where the heel of one foot was 
placed in front of the toes of the other foot. A score of 0 in the balancing 
test indicates the inability to stand in any of the positions; a score of 4 
indicates a full-tandem stand for 10 s 2) Time taken to walk 3 m was then 
estimated, and gait speed calculated as the distance in meters divided by 
the time in seconds. In this test, 0 points indicated the inability to 
perform the walk, and 4 being in the fastest quartile of walking speed 
according to sex and height. 3) The sit-to stand test consisted in standing 
up and sitting down from a chair five times repeatedly, with arms 
crossed across the chest. A score of 0 was given if a participant was 
unable to perform the five chair stands, while scores of 1, 2, 3, or 4 were 
assigned to participants who completed five chair stands in ≥16.7, 
13.7–16.6, 11.2–13.6, and ≤11.1 s, respectively. The total SPPB score 
was calculated by the sum of the components, with a range from 0 to 12 
(best performance). Participants with a score ≤9 were deemed to have a 
low SPPB. 
Mobility disability: In both studies, mobility disability was evaluated 
with three questions from the Rosow and Breslau scale asked as follows: 
In NHANES: 1) “By yourself and without using any special equipment, 
how much difficulty do you have lifting or carrying something as heavy 
as 10 pounds like a sack of potatoes or rice?“, 2) “By yourself and 
without using any special equipment, how much difficulty do you have 
walking for about 2 or 3 blocks?“, 3) “By yourself and without using any 
special equipment, how much difficulty do you have walking up to 10 
steps without resting?“; In the Seniors-ENRICA-2: 1) “How much diffi-
culty do you experience picking up or carrying a shopping bag?“, 2) 
“How much difficulty do you experience climbing one flight of stairs?“, 
3) “How much difficulty do you experience walking several city blocks 
(a few hundred meters)?“; Individuals who answered “some difficulty”, 
“much difficulty”, or “unable to do” to any of these three questions were 
considered as having mobility disability. 
Agility disability: Impaired agility was evaluated with the question 
“By yourself and without using any special equipment, how much dif-
ficulty do you have stooping, crouching, or kneeling?” in NHANES; and 
the question “How much difficulty do you experience in bending or 
kneeling?” in the Seniors-ENRICA-2. Individuals who answered “some 
difficulty”, “much difficulty”, or “unable to do” were considered to have 
agility limitations. 
Frailty: Based on the Rockwood’s frailty index [16], a Deficit Accu-
mulation (DA) Index was calculated using a total of 52 health deficits, 
including impairments in physical and cognitive functioning, 
self-reported health and vitality problems, mental health conditions, as 
well as morbidity, polypharmacy, and health services use [17]. The DA 
index summarizes age-related vulnerability, so the more health deficits 
(symptoms, signs, diseases, or disabilities) an individual has the higher 
the risk of death, institutionalization, health service use, or further 
deficit accumulation. Participants in the highest (worst) quintile of DA 
index were considered frail. 
Disability in Instrumental Activities of Daily living (IADL): Complete 
information on instrumental activity disabilities was only available in 
the Seniors-ENRICA-2, where the Lawton-Brody index evaluated the 
individual’s ability to use the telephone, go shopping, prepare meals, do 
the housework, do the laundry, use different means of transportation, 
take medication, and manage finances. Due to cultural issues, the 
questions on meal preparation, housework and laundry were excluded 
in men. Because the incidence of IADL disability was low (n = 1), pro-
spective analyses using this outcome were not performed. In NHANES, 
information was only available for limitations doing housework, man-
aging finances and preparing meals. In both studies, individuals with 
disability in 1 or more of the evaluated activities were considered as 
IADL disabled. 
3.3. Other variables 
In both studies information from the following variables was also 
collected: age; sex; education (<high school, high school and > high 
school); smoking (never, ex-smoker, current smoker); moderate and 
vigorous physical activity; diet quality (measured with the 14-point 
Mediterranean diet adherence screener (MEDAS [18]) score in the 
Seniors-ENRICA and with a self-reported overall diet quality question in 
NHANES); and history of physician-diagnosed chronic conditions (i.e. 
hypertension, coronary heart disease, congestive heart failure, angina, 
cancer at any site, diabetes, osteoarthritis, and, in the 
Seniors-ENRICA-2, depression). In NHANES, depressive symptoms were 
screened by using the validated Patient Health Questionnaire (PHQ-9) 
[19]. A PHQ-9 score≥10 was considered to indicate depressive symp-
toms. Cardiovascular disease (CVD) was defined as a self-reported 
diagnosis of coronary heart disease, congestive heart failure, heart 
attack or angina. Definition of hypertension was based on a self-reported 
physician diagnosis, current use of anti-hypertensive medication, or a 
clinical blood pressure reading 140/90 mmHg taken under standardized 
conditions. Definition of type 2 diabetes mellitus was based on a 
self-reported physician diagnosis, fasting glucose ≥126 mg/dL, or cur-
rent use of anti-diabetic medication. Weight and height were measured 
according to standardized procedures, and the body mass index (BMI) 
calculated as measured weight in kg divided by squared height in m. 
Information on race/ethnicity was also registered in NHANES (Non--
Hispanic White, Non-Hispanic Black, Mexican-American, and Other). 
3.4. Statistical analyses 
We first examined differences in the distribution of Se biomarkers by 
sociodemographic, lifestyle and clinical characteristics of study partic-
ipants. In NHANES, all analyses were conducted taking into account the 
sampling design and all study statistics account for sampling weights. 
We assessed the cross-sectional (in both surveys) and prospective (in the 
Spanish cohort) associations between concentrations of Se biomarkers 
and measures of physical performance and disability (i.e. limitations in 
lower limb function, grip strength, mobility, agility, and IADL) using 
logistic (for dichotomous outcomes) or linear (for continuous outcomes) 
regression models. 
Se concentrations were modeled as 1) continuous linear terms and 
scaled by the interquartile range; 2) quartiles; 3) log base 2-transformed; 
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Table 1 
Geometric mean [95%CI] concentrations of whole blood and serum selenium by study participants’ characteristics.   
NHANES 2011–2014 Seniors-ENRICA-22017  














Overall* 1733 [100.0] 192.3 [189.4; 
195.2]  
736 [100.0] 129.7 [126.8; 
132.8]  
2548 [100.0] 113.4 [112.6; 
114.3]  
Age,yr          
65-69 865 [49.9] 193.9 [190.7; 
197.1]  
365 [46.6] 129.8 [126.9; 
132.7]  
946 [37.1] 117.2 [115.9; 
118.4]  
70-74 347 [20.0] 195.5 [191.5; 
199.6]  
171 [26.6] 129.7 [126.3; 
133.2]  
979 [38.4] 114.0 [112.8; 
115.2]  
≥75 521 [30.1] 187.1 [182.1; 
192.2] 
0.004 200 [26.8] 129.8 [124.0; 
135.9] 
0.996 623 [24.5] 107.0 [105.5; 
108.5] 
0.000 
Sex          
Men 841 [43.9] 196.5 [192.7; 
200.5]  
360 [47.5] 133.9 [128.7; 
137.4]  
1199 [47.1] 113.5 [112.5; 
114.6]  
Women 892 [56.1] 189.1 [186.4; 
191.7] 
0.000 376 [52.5] 126.9 [123.8; 
130.0] 
0.016 1349 [52.9] 113.3 [112.2; 
114.4] 
0.768 
Ethnicity          
Non-Hispanic white 872 [81.7] 192.1 [188.8; 
195.5]  
388 [46.9] 131.1 [125.5; 
136.9]  
2548 [100.0] 113.4 [112.6; 
114.3]  
Non-Hispanic black 415 [ 7.6] 189.4 [185.5; 
193.4]  
170 [25.8] 125.4 [122.6; 
128.3]     
Mexican-American 128 [ 2.8] 195.4 [190.1; 
200.8]  
55 [5.7] 124.2 [115.6; 
133.5]     
Other & multi-racial 318 [ 7.9] 195.9 [190.7; 
201.3] 
0.058 123 [21.6] 133.6 [129.5; 
137.8] 
0.005    
Education          
<High School 445 [17.0] 189.9 [193.3; 
197.0]  
194 [36.9] 128.1 [122.1; 
134.4]  
1613 [63.3] 112.2 [111.3; 
113.2]  
High School 408 [22.0] 188.4 [184.2; 
192.6]  
163 [17.5] 133.5 [126.4; 
141.0]  
481 [18.9] 113.9 [112.2; 
115.7]  
>High School 880 [61.0] 194.4 [191.5; 
197.3] 
0.018 379 [45.6] 129.7 [126.2; 
133.3] 
0.329 454 [17.8] 117.0 [115.0; 
119.0] 
0.000 
BMI, kg/m2          
Under/normoweight, <25, 456 [27.2] 188.7 [185.7; 
191.8]  
192 [26.2] 131.1 [127.5; 
134.7]  
683 [26.8] 114.0 [112.4; 
115.6]  
Overweight, 25–29.9, 606 [36.1] 195.9 [190.8; 
201.2]  
263 [37.1] 130.7 [124.9; 
136.9]  
1209 [47.1] 114.0 [113.0; 
115.1]  
Obese, ≥30, 671 [36.7] 191.4 [188.9; 
194.0] 
0.004 281 [36.7] 127.8 [124.6; 
131.2] 




1st category [worst] 329 [15.4] 188.5 [183.4; 
193.8]  
139 [16.5] 125.0 [119.7; 
130.6]  
870 [34.1] 110.5 [108.9; 
111.5]  
2nd category 734 [40.7] 190.7 [187.2; 
194.3]  
315 [42.4] 129.0 [126.0; 
132.1]  
1237 [48.6] 114.6 [113.6; 
115.7]  
3rd category [best] 670 [43.9] 195.2 [192.0; 
198.3] 
0.003 282 [30.1] 132.5 [128.1; 
137.9] 
0.040 441 [17.3] 116.4 [114.4; 
118.4] 
0.091 
RDA for selenium intake          
<55 μg/d 193 [ 9.5] 182.2 [177.3; 
189.2]  
71 [10.6] 119.5 [115.6; 
123.5]  
9 [0.4] 102.8 [84.2; 
125.4]  
≥55 μg/d 1540 [90.5] 193.3 [177.3; 
189.2] 
0.007 665 [89.4] 131.0 [127.4; 
134.8] 
0.000 2539 [99.6] 113.4 [112.7; 
114.2] 
0.130 
Nº RDA recommendations for 
vitamins          
<5 732 [42.2] 195.4 [192.1; 
198.8]  
286 [36.9] 133.8 [130.7; 
137.0]  
1636 [64.2] 115.3 [114.3; 
116.3]  
≥5 1001 [57.8] 189.7 [189.4; 
193.1] 
0.002 450 [63.1] 127.5 [123.8; 
131.3] 
0.000 912 [35.8] 110.0 [108.8; 
111.2] 
0.000 
Consumption of proteins ≥ 1.2 
g/kg weight ‡
No 1366 [78.0] 190.8 [187.4; 
194.1]  
568 [78.3] 128.5 [125.3; 
131.7]  
1134 [44.5] 111.2 [110.0; 
112.3]  
Yes 367 [22.0] 197.8 [194.9; 
200.9] 
0.001 168 [21.7] 134.4 [129.2; 
138.8] 
0.063 1414 [55.5] 115.2 [114.2; 
116.2] 
0.000 
Consumption of proteins [g/ 
day]          
1st tertile 637 [33.4] 187.2 [183.0; 
191.5]  
246 [34.5] 123.8 [119.8; 
127.9]  
850 [33.4] 110.1 [108.7; 
111.4]  
2nd tertile 555 [33.4] 191.9 [188.7; 
195.2]  
245 [35.5] 131.5 [127.0; 
136.1]  
849 [33.2] 114.1 [112.8; 
115.4]  
3rd tertile 541 [33.2] 198.0 [194.5; 
201.5] 
0.020 245 [30.0] 134.8 [130.1; 
139.7] 
0.016 849 [33.2] 116.1 [114.8; 
117.4] 
0.000          
(continued on next page) 
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and 4) restricted cubic splines with knots at the 10th, 50th, and 90th 
percentile for each cohort and biomarker to evaluate potential non- 
linear relationships. We conducted a test for trend in the association 
between increasing Se quartiles and measures of functional limitations 
by including Se medians corresponding to each quartile as continuous 
variables. Also, we evaluated departures from linearity in the restricted 
cubic spline models using the Wald test. Potential important con-
founders were included in models as follows: Model A adjusted for age, 
sex, and race/ethnicity (in NHANES); model B further adjusted for ed-
ucation, BMI, diet quality, protein intake, number of vitamins with 
intake above RDA, physical activity, smoking status, alcohol 
consumption, and prevalence of hypertension, CVD, diabetes, cancer, 
depression and/or osteoarthritis. 
Between-study heterogeneity was assessed using the chi square 
based Q statistic and quantified using the I2 statistic. Given consistent 
results between NHANES and ENRICA-2 (I2<30%) [20], we used 
random-effects meta-analysis as implemented in STATA using the metan 
command to obtain pooled estimates when possible (similar outcome 
definitions). 
To evaluate the consistency of the findings, we conducted analyses 
for log2 transformed Se and functional limitations stratified by the main 
participant’s subgroups: age (<70, ≥70 years), sex (male, female), BMI 
Table 1 (continued )  
NHANES 2011–2014 Seniors-ENRICA-22017  














Physical activity [METs-hours/ 
week]§
1st tertile 617 [33.4] 189.7 [186.7; 
192.8]  
263 [35.7] 128.6 [124.5; 
132.8]  
850 [32.4] 111.8 [110.4; 
113.2]  
2nd tertile 595 [33.8] 193.2 [189.6; 
196.9]  
263 [36.5] 131.0 [126.5; 
135.5]  
850 [33.4] 114.3 [113.0; 
115.7]  
3rd tertile 521 [32.8] 194.9 [190.0; 
198.1] 
0.039 210 [27–8] 129.7 [125.8; 
133.7] 
0.345 848 [33.2] 114.1 [112.8; 
115.3] 
0.015 
Smoking          
Never 860 [49.6] 192.7 [189.5; 
195.9]  
353 [47.7] 129.8 [126.4; 
133.3]  
1341 [52.6] 113.3 [112.2; 
114.4]  
Ex-smoker 689 [39.8] 192.9 [189.3; 
196.6]  
314 [41.6] 130.6 [126.3; 
135.2]  
967 [38.0] 114.2 [112.9; 
115.3]  
Current 184 [10.6] 187.3 [180.1; 
194.9] 
0.252 69 [10.7] 126.1 [121.1; 
131.4] 
0.325 240 [9.4] 110.6 [108.4; 
112.8] 
0.043 
Alcohol consumption          
Not current 562 [28.7] 188.9 [185.1; 
192.8]  
238 [39.7] 127.5 [123.2; 
132.0]  
488 [19.2] 110.8 [108.9; 
112.7]  
Current 1179 [71.3] 193.7 [190.1; 
196.6]  
497 [60.3] 131.3 [127.8; 
134.9]  
1896 [74.4] 189.6 [113.4; 
115.1]  
Ex-drinkers   0.004   0.136 164 [6.4] 164.0 [108.4; 
114.4] 
0.000 
Hypertension          
No 550 [36.9] 193.9 [189.5; 
198.3]  
242 [31.0] 132.7 [129.1; 
136.1]  
810 [31.8] 114.3 [112.8; 
115.7]  
Yes 1183 [63.1] 191.4 [188.4; 
194.4] 
0.251 494 [69.0] 128.5 [124.9; 
132.2] 
0.096 1738 [68.2] 113.0 [112.1; 
113.9] 
0.121 
Cardiovascular disease          
No 1359 [79.5] 193.1 [189.7; 
196.5]  
581 [78.9] 131.3 [128.1; 
134.5]  
2460 [96.6] 113.7 [112.9; 
114.4]  
Yes 374 [20.5] 189.3 [185.9; 
192.9] 
0.077 155 [22.5] 124.7 [118.2; 
131.5] 
0.083 88 [3.4] 105.8 [100.8; 
110.9] 
0.000 
Diabetes mellitus          
No 1438 [77.6] 192.4 [189.3; 
195.6]  
529 [71.3] 129.6 [126.8; 
132.5]  
2030 [76.7] 114.2 [113.3; 
115.1]  
Yes 576 [22.4] 192.0 [188.1; 
196.0] 
0.833 207 [28.7] 130.1 [123.8; 
136.7] 
0.877 518 [20.3] 110.1 [108.6; 
111.7] 
0.000 
Cancer          
No 1380 [75.1] 192.8 [189.9; 
195.9]  
588 [79.1] 129.6 [127.3; 
132.0]  
2471 [97.0] 113.5 [112.7; 
114.3]  
Yes 353 [24.9] 190.7 [187.2; 
194.3] 
0.128 148 [20.9] 130.2 [122.8; 
138.1] 
0.858 77 [3.0] 110.6 [106.8; 
114.5] 
0.206 
Osteoartritis          
No 876 [50.7] 192.2 [188.2; 
196.3]  
371 [47.6] 129.7 [126.5; 
133.0]  
1399 [54.9] 114.9 [113.8; 
115.9]  
Yes 857 [49.3] 192.4 [189.4; 
195.3] 
0.954 365 [52.4] 129.8 [125.9; 
133.8] 
0.969 1149 [45.1] 111.6 [100.5; 
112.7] 
0.000 
Depression          
No 1604 [94.9] 192.5 [189.3; 
195.7]  
680 [93.3] 130.5 [127.5; 
133.7]  
2337 [91.7] 113.6 [112.8; 
114.4]  
Yes 129 [ 5.1] 188.7 [181.4; 
196.2] 
0.396 56 [6.7] 119.9 [109.1; 
131.8] 
0.093 211 [8.3] 110.8 [107.4; 
114.2] 
0.043 
P-values correspond to Wald tests obtained from regression models on log-transformed selenium. *Based on participants with information in at least one functional 
variable. † The first, second and third categories correspond to participants with a fair or poor diet, a good diet, and an excellent or very good diet in the NHANES; or 
participants in the first, second, and third tertiles of the MEDAS score in the Seniors-ENRICA II. Cutoff values for the MEDAS score were <6 [tertile 1], 7–8 [tertile 2], 
and ≥9 [tertile 3].‡ Based on the subsample of participants with this information available. §Cutoff values for moderate and vigorous physical activity [METs-hours/ 
week] were 1/24 in men and 1/20 in women in the NHANES; and 1.6/13.2 in men and 4/5.2 in women in the Seniors-ENRICA II. 




Cross-sectional association between whole blood selenium and measures of impaired physical function and disability in older adults from the NHANES and Seniors-ENRICA II studies. Results are odds ratios [95% 
confidence interval].     
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(<30, ≥30 kg m2), physical activity (tertiles METs hours/week), chronic 
morbidities, diet quality (tertiles), daily protein intake (tertiles g/kg/d), 
adequate daily protein intake (≤1.2, >1.2 g per kg of weight), RDA for 
selenium intake (≥55,<55 μg/day), and number of vitamins with intake 
below the RDA (≤5,>5). Effect-modification was tested with likelihood 
ratio tests that compared models with and without interaction terms. 
Additionally, we conducted interaction analyses according to partici-
pant’s compliance with the RDA for each vitamin. As a sensitivity 
analysis, we adjusted ENRICA models for intake of animal and vegetable 
proteins, separately, yielding similar findings. 
We performed all analyses with Stata version 14.1 (StataCorp LP, 
College Station, TX). 
4. Results 
Geometric means [GM] and their 95% confidence intervals [CI] for 
whole blood Se in NHANES and Seniors-ENRICA-2 were 192.3 μg/L 
[189.4; 195.2] and 113.4 μg/L [112.6; 114.3], respectively (Table 1). 
The GM for serum Se in NHANES was 129.7 μg/L [126.8; 132.8]. Among 
NHANES participants, the population weighted correlation between 
whole blood Se and serum Se, was 0.7. 
Whole blood Se levels decreased with age, and were higher among 
participants with higher education and higher physical activity. Both 
whole blood and serum Se levels were lower in participants who met the 
RDA for ≥5 vitamins, with lower diet quality, whose daily Se and pro-
tein intake were below 55 μg or 1.2 g/kg, respectively, current smokers, 
not current drinkers, and participants with CVD and depression. In the 
NHANES, blood and serum Se levels where lower in Non-Hispanic black 
women compared to their counterparts (Table 1). 
Physical function limitations were common. In NHANES, 20.3%, 
40.0%, 16.1% and 20.5% participants showed impaired lower-extremity 
function, mobility disability, agility limitations, or disability in any of 
the 3 evaluated Lawton instrumental activities. In the ENRICA-2, 26.7%, 
38.2%, 57.2%, and 7.5% had impaired lower-extremity function, 
mobility disability, agility limitations, or IADL disability, respectively 
(Table 2). 
In multivariable analyses, the frequency of functional limitations was 
lower in individuals with higher whole blood Se concentrations 
(Table 2). Meta-analyzed odds ratios (95% confidence intervals) for a 2- 
fold increase in whole blood Se were 0.54 (0.32; 0.76) for weakness, 
0.59 (0.34; 0.83) for impaired lower-extremity performance, 0.48 (0.31; 
0.68) for mobility disability, 0.71 (0.45; 0.97) for agility limitations, and 
0.34 (0.12; 0.56) for having at least one IADL disability. Additionally, in 
the Seniors-ENRICA-2, the odds ratio (95% confidence interval) of 
frailty for a 2-fold increase in Se concentrations was 0.25 (0.15; 0.42). 
Fig. 1 represents differences in grip strength as a smooth function of 
whole blood Se in both studies; to facilitate comparisons between them, 
the reference value was set at 140 μg/L, corresponding to the 90th 
percentile of Se distribution in the Seniors-ENRICA-2 population. Find-
ings suggest that the inverse association is progressive below 140 μg/L 
(p-value for non-linear trend and for linear trend in the ENRICA study =
0.131 and 0.012, respectively), and thereafter (p-value for non-linear 
trend and for linear trend in NHANES = 0.112 and 0.005, respectively). 
After a mean follow up period of 2.2 years in the Seniors-ENRICA-2 
cohort, we identified 181, 260, 214, 238, 403, and 1 incident cases of 
weakness, SPPB ≤9, mobility disability, agility disability, and IADL 
disability, respectively (Table 3). In multivariable analyses, baseline 
whole blood Se concentrations were associated with a decreased inci-
dence of weakness [odds ratio log2 (95% confidence interval): 0.45 
(0.22; 0.91)], impaired lower extremity functional performance [0.63 
(0.32; 1.23)], mobility disability [0.43 (0.21; 0.91)], agility limitations 
[0.38 (0.18; 0.78)], and frailty [0.42 (0.20; 0.90)]. 
Analyses for the association between serum Se and prevalence of 
functional limitations in the subset of NHANES participants with this 
information available (Table 4) showed no overall association with 
weakness [odds ratio log2 (95%CI): 1.05 (0.15; 7.16); n = 691 partici-
pants with serum Se)], but an inverse association with mobility 
disability [0.22 (0.05; 1.00); n = 695]. Inverse associations were also 
observed for standing difficulties, agility limitations and IADL limita-
tions, but these were no longer significant after multivariate adjustment 
[0.87 (0.58; 1.29), n = 735; 0.12 (0.01; 1.30), n = 728; and 0.13 (0.01; 
1.60), n = 676; respectively.]. 
In stratified analyses (Supplementary Table S1 and S2), no 
consistent interactions were observed across functional variables and 
cohorts. 
5. Discussion 
In US and Spanish older adults, Se concentrations in whole blood 
were inversely associated with physical function limitations, with a very 
consistent magnitude of associations observed across studies. These as-
sociations were independent of protein intake or diet quality and were 
maintained after 2.2 years of follow-up in the Spanish cohort. In general, 
there was a good agreement between concentrations and determinants 
of whole blood and serum Se and, although most results for serum Se did 
not achieve statistical significance, findings for both Se biomarkers were 
consistent for most functional variables. 
When nutritional adequacy is being assessed, functional biomarkers 
quickly responsive to changes in diet, such as selenoproteins, are the 
biomarkers of choice to evaluate exposure to Se. In this regard, samples 
of plasma and serum Se, which are virtually equivalent with respect to 
Se-containing components, are especially useful to monitor Se status in 
supplementation studies [21], even at doses above the tolerable upper 
intake level [22]. Whole blood Se, on the other hand, has been proposed 
as a better indicator of intermediate to long term average exposure [21], 
with slower responses to recent changes in dietary intake [23]. 
As noted in the introduction, some studies have already described 
consistent cross-sectional associations between Se biomarkers and 
muscular function [3–5]. Skeletal muscle is one of the major sites of Se 
Fig. 1. Average differences in grip strength values by whole blood selenium 
concentrations. Curves represent average differences in grip strength [solid 
lines] and their 95%confidence intervals [dashed lines] based on restricted 
quadratic splines with knots at the 10, 50, and 90th percentiles of selenium 
distribution in participants from each study. The reference values were set at 
140 μg/L, corresponding to the 90th percentile of Se distribution in the ENRICA 
population]. Results were obtained from linear regression models adjusted for 
age, sex [men or women], educational level [< high school, high school, or >
high school], BMI [<25, 25–29.9, ≥30 kg/m2] race/ethnicity [only in 
NHANES], diet quality [continuous], protein intake [tertiles], number of vita-
mins with intake above RDA [continuous], moderate and vigorous physical 
activity [METs-hours/week in tertiles], smoking status [never, ex-smoker, 
current], alcohol consumption [never/ex-drinkers/current drinkers] diet qual-
ity, BMI [<25, 25–29.9, ≥30 kg/m2], and comorbidities [hypertension, car-
diovascular disease, diabetes, cancer, depression and osteoarthritis]. 




Prospective association between whole blood selenium and risk of impaired physical function and disability in the Seniors-ENRICA II study. Results are odds ratios [95% confidence interval].     
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IADL: Instrumental Activities of Daily Living. 
Model A is adjusted for age, sex. Model B is further adjusted for education, BMI, diet quality, protein intake, number of vitamins with intake above RDA, physical activity, smoking status, alcohol consumption, and 
comorbidities [hypertension, cardiovascular disease, diabetes, cancer, depression and osteoarthritis]. * p-values for linear trend were obtained by using an ordinal variable with the median selenium concentrations in each 
category. 
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storage (approximately between 30 and 45% of the total pool) and 
several selenoproteins have been involved in muscular function. The 
most well-known is selenoprotein N, whose deficiency, caused by mu-
tations in the human gene, has been associated with several neuro-
muscular disorders [34]. In vivo, mice supplementation with Se show 
increases in selenoprotein N synthesis and expression, which translate 
into better calcium release from the sarcoplasmic reticulum [35,36]. 
Other selenoproteins like selenoprotein K or selenoprotein W influence 
the normal physiology of skeletal muscle, but their precise functions has 
yet to be elucidated [2,37,38]. Potential increases in circulating and 
intracellular selenoprotein expression at the observed intake levels are 
compatible with a protective effect of Se on muscular function brought 
about by selenoenzymes. 
Previous epidemiological research has found evidence of other po-
tential health benefits of Se status in older populations, such as a 
reduced risk of immune dysfunction [24,25], cognitive decline [26], 
cardiovascular disease [27], certain tumors [25], or overall mortality 
[28–32]. In all these processes, Se is probably contributing to the alle-
viation of reduced reactive oxygen species-mediated inflammation, 
reduced DNA damage or prolonged telomere length [33]. Still, there is 
concern that some of these effects may revert at high levels of exposure. 
Our results should be interpreted with caution. Although analyses in 
participants with follow-up information confirmed our cross-sectional 
findings, the duration of follow-up was short and reverse causation 
cannot be ruled out. Concentrations of circulating micronutrient bio-
markers in older institutionalized adults can be altered in the presence of 
inflammation [39], a central mechanism in age-related function im-
pairments [41]. According to this, inflammation could mediate redis-
tribution of Se from plasma to the liver, with reductions in blood 
concentrations that may not necessarily reflect true micronutrient 
deficiency [39]. Unfortunately, we could not address this hypothesis, 
although a bidirectional relationship likely exists. 
This work has several strengths. First, it is the largest to date eval-
uation of association between biomarkers of Se exposure and functional 
outcomes in humans. We made an effort to ensure the replicability of the 
results in two different populations, including a representative sample of 
the US population. Despite these populations showing very different 
exposures to Se, mainly attributed to differences in Se soil content and 
use of supplements [24], results showed consistent findings. Second, we 
adjusted our models and addressed interactions by a great number of 
variables, including important determinants of muscular function like 
protein and vitamin intake, or diet quality [42–44]. And third, we used 
different biomarkers of Se exposure and a number of validated measures 
of physical function, and we applied different methods to model the 
potential non-linear dose-response relationship between Se and func-
tional variables. 
Our results provide evidence for a link between Se and functional 
limitations in older adults. Experimental studies as well as long-term 
follow-up studies with biological biomarkers of inflammation are 
needed to understand the physio-pathological mechanisms underlying 
the observed associations. 
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Model A is adjusted for age, sex, and ethnicity [in NHANES]. Model B 
is further adjusted for education, BMI, diet quality, protein intake, 
number of vitamins with intake above RDA, physical activity, smoking 
status, alcohol drinking, and comorbidities [hypertension, cardiovas-
cular disease, diabetes, cancer, depression and osteoarthritis]. * p-values 
for linear trend were obtained by using an ordinal variable with the 
median selenium concentrations in each category. 
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